VIPR1 Antikörper (AA 351-457)
-
- Target Alle VIPR1 Antikörper anzeigen
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
-
Bindungsspezifität
- AA 351-457
-
Reaktivität
- Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VIPR1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Maus, Ratte
- Homologie
- Human,Cow,Pig,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human VIP Receptor 1/VAPC1
- Isotyp
- IgG
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
Enteromorpha and polysaccharides from enteromorpha ameliorate loperamide-induced constipation in mice." in: Biomedicine & pharmacotherapy, Vol. 96, pp. 1075-1081, (2018) (PubMed).
: "
-
Enteromorpha and polysaccharides from enteromorpha ameliorate loperamide-induced constipation in mice." in: Biomedicine & pharmacotherapy, Vol. 96, pp. 1075-1081, (2018) (PubMed).
-
- Target
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
- Andere Bezeichnung
- VIP Receptor 1 (VIPR1 Produkte)
- Synonyme
- HVR1 antikoerper, II antikoerper, PACAP-R-2 antikoerper, PACAP-R2 antikoerper, RDC1 antikoerper, V1RG antikoerper, VAPC1 antikoerper, VIP-R-1 antikoerper, VIPR antikoerper, VIRG antikoerper, VPAC1 antikoerper, VPAC1R antikoerper, VPCAP1R antikoerper, CVIPR antikoerper, AV071699 antikoerper, VIP-R1 antikoerper, RATVASREC antikoerper, VASREC antikoerper, VIPR1 antikoerper, LOC100226500 antikoerper, vipr1 antikoerper, hvr1 antikoerper, rdc1 antikoerper, v1rg antikoerper, vipr antikoerper, virg antikoerper, vapc1 antikoerper, vpac1 antikoerper, vpcap1 antikoerper, vpac1-r antikoerper, VIP-R antikoerper, vasoactive intestinal peptide receptor 1 antikoerper, vasoactive intestinal peptide receptor 1b antikoerper, vasoactive intestinal peptide receptor 1 S homeolog antikoerper, vasoactive intestinal polypeptide receptor antikoerper, VIPR1 antikoerper, Vipr1 antikoerper, vipr1b antikoerper, vipr1 antikoerper, vipr1.S antikoerper, LOC100303683 antikoerper
- Hintergrund
-
Synonyms: II, HVR1, RDC1, V1RG, VIPR, VIRG, VAPC1, VPAC1, VPAC1R, VIP-R-1, VPCAP1R, PACAP-R2, PACAP-R-2, Vasoactive intestinal polypeptide receptor 1, Pituitary adenylate cyclase-activating polypeptide type II receptor, PACAP type II receptor, VIPR1
Background: This is a receptor for VIP. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. The affinity is VIP = PACAP-27 > PACAP-38.
- Gen-ID
- 7433
- UniProt
- P32241
-